[1]
2025. Assessment Of Quality-Of-Life Improvement In Severe Haemophilia-A With Inhibitor Patients Receiving Emicizumab Prophylaxis – Hospital Based Prospective Observational Study - Original Research Article. The Review of Diabetic Studies . (Aug. 2025), 579–583. DOI:https://doi.org/10.70082/9n07nr44.